{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:42:47Z","timestamp":1793216567764,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003412.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000}}],"reference-count":173,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003412.pub3","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T13:56:30Z","timestamp":1605621390000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Interventions for basal cell carcinoma of the skin"],"prefix":"10.1002","volume":"2020","author":[{"given":"Jason","family":"Thomson","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Royal London Hospital, Barts Health NHS Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hogan","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Royal London Hospital, Barts Health NHS Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Leonardi-Bee","sequence":"additional","affiliation":[{"name":"Centre for Evidence Based Healthcare, Division of Epidemiology and Public Health, Clinical Sciences Building Phase 2; University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hywel C","family":"Williams","sequence":"additional","affiliation":[{"name":"Centre of Evidence Based Dermatology; University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona J","family":"Bath-Hextall","sequence":"additional","affiliation":[{"name":"Emeritus Professor, Evidence Based Health Care; University of Nottingham; Nottingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"10.1002\/14651858.CD003412.pub3-BIB0001|cit1","unstructured":"A randomised, double-blinded parallel group study to compare efficacy and tolerability of topically applied Baceca and Tazarotene against placebo and Tazarotene in patients with basal cell carcinoma www.clinicaltrialsregister.eu\/ctr-search\/trial\/2005-001474-27\/results"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD003412.pub3-BIB0002|cit2","first-page":"AB185","article-title":"Higher recurrence rates of head and neck nodular basal cell carcinoma treated with topical photodynamic therapy (MAL-PDT) compared to surgical excision: a randomized controlled study","volume":"72","author":"Abbade","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4103\/ijdvl.IJDVL_644_17","article-title":"Pulsed dye laser in the treatment of basal cell carcinoma: a single session versus two sessions\u2013a randomized controlled trial","volume":"85","author":"Abd El-Naby","year":"2019","journal-title":"Indian Journal of Dermatology, Venereology, and Leprology"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1346-8138.1996.tb04040.x","article-title":"Comparison of the effects of intralesional interferon alfa-1a, 2b and the combination of 2a and 2b in the treatment of basal cell carcinoma","volume":"23","author":"Alpsoy","year":"1996","journal-title":"Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003412.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncology"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaad.2018.04.053","article-title":"Comparison of long-term cosmetic outcomes for different treatments of superficial basal cell carcinoma","volume":"79","author":"Jansen","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jid.2017.09.033","article-title":"Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical Imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma","volume":"138","author":"Jansen","year":"2018","journal-title":"Journal of Investigative Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003412.pub3-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jid.2016.03.043","article-title":"Three-year follow-up results of photodynamic therapy vs. imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial","volume":"136","author":"Roozeboom","year":"2016","journal-title":"Journal of Investigative Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/bjc.1997.343","article-title":"Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study","volume":"76","author":"Avril","year":"1997","journal-title":"British Journal of Cancer"},{"issue":"7","key":"10.1002\/14651858.CD003412.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1097\/00006534-200006000-00039","article-title":"Evaluation of cosmetic results of a randomised trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face","volume":"105","author":"Petit","year":"2000","journal-title":"Plastic and Reconstructive Surgery"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0011|cit11","first-page":"29","article-title":"Methyl aminolaevulinate photodynamic therapy vs. cryotherapy in primary superficial basal cell carcinoma: results of a 36-month follow-up","volume":"153","author":"Basset-Seguin","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0012|cit12","first-page":"547","article-title":"Topical methyl aminolevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial","volume":"18","author":"Basset-Seguin","year":"2008","journal-title":"European Journal of Dermatolology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1470-2045(13)70530-8","article-title":"Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial","volume":"15","author":"Bath-Hextall","year":"2014","journal-title":"Lancet Oncology"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jid.2016.10.019","article-title":"Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial","volume":"137","author":"Williams","year":"2017","journal-title":"Journal of Investigative Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0190-9622(99)70261-6","article-title":"Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream","volume":"41","author":"Beutner","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaad.2016.01.050","article-title":"The effect of topical diclofenac 3% and calcitriol 3 \u03bcg\/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): a phase II, randomized controlled trial","volume":"75","author":"Brinkhuizen","year":"2016","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/jdv.13453","article-title":"Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial","volume":"30","author":"Choi","year":"2015","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1097\/CMR.0000000000000285","article-title":"Prospective randomised control trial comparing electrochemotherapy and surgery for the primary treatment of basal cell carcinoma","volume":"26","author":"Clover","year":"2016","journal-title":"Melanoma Research"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ejso.2019.11.509","article-title":"Electrochemotherapy for the treatment of primary basal cell carcinoma; a randomised control trial comparing electrochemotherapy and surgery with five year follow up","volume":"46","author":"Clover","year":"2020","journal-title":"European Journal of Surgical Oncology"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD003412.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0190-9622(90)70276-N","article-title":"Intralesional interferon therapy for basal cell carcinoma","volume":"23","author":"Cornell","year":"1990","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003412.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archderm.1990.01670320053006","article-title":"The effects of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinoma","volume":"126","author":"Edwards","year":"1990","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003412.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaad.2007.05.022","article-title":"A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma","volume":"57","author":"Eigentler","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5 (S1)","key":"10.1002\/14651858.CD003412.pub3-BIB0023|cit23","first-page":"AB134","article-title":"Effectiveness of a 595-nm pulsed dye laser for the treatment of basal cell carcinoma using 1 stacked-pulse session","volume":"70","author":"Eimpunth","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/09546630701557965","article-title":"A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma","volume":"19","author":"Ezughah","year":"2008","journal-title":"Journal of Dermatological Treatment"},{"issue":"11","key":"10.1002\/14651858.CD003412.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-4632.2008.04022.x","article-title":"Photodynamic therapy with methyl aminolevulinate from primary nodular basal cell carcinoma:results of two randomized studies","volume":"48","author":"Foley","year":"2009","journal-title":"International Journal of Dermatology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD003412.pub3-BIB0026|cit26","first-page":"231","article-title":"A phase III randomized study comparing photodynamic therapy (PDT) using methyl aminolevulinate or placebo cream in nodular basal cell carcinoma (NBCC)","volume":"17","author":"Foley","year":"2003","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"11","key":"10.1002\/14651858.CD003412.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1365-4632.2008.04022.x","article-title":"Photodynamic therapy with methyl aminolevulinate from primary nodular basal cell carcinoma:results of two randomized studies","volume":"48","author":"Foley","year":"2009","journal-title":"International Journal of Dermatology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0028|cit28","unstructured":"Tope WD Menter A El Azhary R Soto P A comparison of topical MAL-PDT versus placebo-PDT in nodular basal cell carcinoma: results of a North American study 7th Asian Congress of Dermatology incorporating the 5th Regional Conference of Paediatric Dermatology; 2005 Sep 28-Oct 03; Kuala Lumpur, Malaysia 2005 376"},{"issue":"10","key":"10.1002\/14651858.CD003412.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bjo.2010.193078","article-title":"Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma","volume":"95","author":"Garcia-Martin","year":"2011","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0030|cit30","unstructured":"Geisse JK Marks R Owens ML Andres K Ginkel AM Imiquimod 5% cream for 12 weeks treating superficial BCC The 8th World Congress on Cancer of the Skin; 2001 July 18-21; Zurich, Switzerland 2001 P58"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1067\/mjd.2002.126215","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a randomized, vehicle-controlled study","volume":"47","author":"Geisse","year":"2002","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies","volume":"50","author":"Geisse","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/bjd.13166","article-title":"Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas - a randomized clinical trial","volume":"172","author":"Haak","year":"2015","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0009-9260(86)80161-1","article-title":"Treatment of basal cell carcinoma: comparison of radiotherapy and cryotherapy","volume":"37","author":"Hall","year":"1986","journal-title":"Clinical Radiology"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/bjd.13266","article-title":"The role of the 595-nm pulsed dye laser in treating superficial basal cell carcinoma: Outcome of a double-blind randomized placebo-controlled trial","volume":"172","author":"Karsai","year":"2015","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD003412.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamadermatol.2017.2529","article-title":"Topical sinecatechins, 10%, ointment for superficial basal cell carcinoma: A randomized clinical trial","volume":"153","author":"Kessels","year":"2017","journal-title":"JAMA Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bjd.15967","article-title":"Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolaevulinic acid 20% vs. two-stage topical methyl aminolaevulinate: results of a randomized controlled trial","volume":"178","author":"Kessels","year":"2018","journal-title":"British Journal of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003412.pub3-BIB0038|cit38","first-page":"642","article-title":"Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma","volume":"5","author":"Kuijpers","year":"2006","journal-title":"Journal of Drugs in Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0039|cit39","first-page":"579","article-title":"Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma","volume":"33","author":"Kuijpers","year":"2007","journal-title":"Dermatologic Surgery"},{"issue":"8","key":"10.1002\/14651858.CD003412.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1524-4725.2000.ds00064.x","article-title":"Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck","volume":"26","author":"Thissen","year":"2000","journal-title":"Dermatologic Surgery"},{"issue":"12","key":"10.1002\/14651858.CD003412.pub3-BIB0041|cit41","first-page":"774","article-title":"Use of the TDF factor in soft roentgen radiotherapy","volume":"40","author":"Landthaler","year":"1989","journal-title":"Hautarzt"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1067\/mjd.2001.113689","article-title":"Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicentre 6-week dose-response trial","volume":"44","author":"Marks","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0190-9622(97)70328-1","article-title":"Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil\/epinephrine injectable gel","volume":"36","author":"Miller","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0044|cit44","first-page":"309","article-title":"A randomized, multi-national, non-inferiority, phase III trial to evaluate the safety and efficacy of BF-200 ALA gel versus MAL cream in the treatment of non-aggressive basal cell carcinoma with photodynamic therapy (PDT)","volume":"179","author":"Morton","year":"2018","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003412.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-2133.2008.08787.x","article-title":"Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial","volume":"159","author":"Mosterd","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jid.2016.03.043","article-title":"Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up","volume":"69","author":"Roozeboom","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-4632.2007.03363.x","article-title":"Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicentre study","volume":"47","author":"Punjabi","year":"2008","journal-title":"International Journal of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003412.pub3-BIB0048|cit48","first-page":"49","article-title":"A double-blind, multicentre parallel group study of BEC-5 cream in basal cell carcinoma","volume":"14","author":"Punjabi","year":"2000","journal-title":"European Academy of Dermatology & Venereology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archderm.140.1.17","article-title":"Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma","volume":"140","author":"Rhodes","year":"2004","journal-title":"Archives of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD003412.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archderm.143.9.1131","article-title":"Five year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma","volume":"143","author":"Rhodes","year":"2007","journal-title":"Archives of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0051|cit51","first-page":"259","article-title":"Intralesional treatment with recombinant interferon beta is an effective alternative for the treatment of basal cell carcinoma. Double-blind, placebo-controlled study.","volume":"84","author":"Rogozinski","year":"1997","journal-title":"Przeglad Dermatologiczny"},{"issue":"4","key":"10.1002\/14651858.CD003412.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1524-4725.2000.99227.x","article-title":"A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier","volume":"26","author":"Romagosa","year":"2000","journal-title":"Dermatologic Surgery"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0053|cit53","first-page":"66","article-title":"Efficacy of excisional surgery, curettage and combined curettage and electrodessication in treatment of basal cell carcinoma","volume":"15","author":"Salmanpoor","year":"2012","journal-title":"Iranian Journal of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD003412.pub3-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1016\/j.jid.2019.07.119","article-title":"Hexylaminolevulinate and aminolevulinic acid nanoemulsion have similar tolerability, initial efficacy and cosmetic outcome as methylaminolevulinate in photodynamic therapy of basal cell carcinoma in a prospective randomized double-blinded trial","volume":"139","author":"Salmivuori","year":"2019","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1365-2133.2005.06486.x","article-title":"Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe","volume":"152","author":"Schulze","year":"2005","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0056|cit56","first-page":"p55","article-title":"Imiquimod 5% cream for 6 weeks treating nodular BCC","volume":"-","author":"Shumack","year":"2001","journal-title":"8th World Congress on Cancers of the Skin, Zurich, Switzerland"},{"issue":"9","key":"10.1002\/14651858.CD003412.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archderm.138.9.1165","article-title":"Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens","volume":"138","author":"Shumack","year":"2002","journal-title":"Archives of Dermatology"},{"issue":"-","key":"10.1002\/14651858.CD003412.pub3-BIB0058|cit58","first-page":"p57","article-title":"Imiquimod 5% cream for 12 weeks treating nodular BCC","volume":"-","author":"Robinson","year":"2001","journal-title":"8th World Congress on Cancer of the Skin, Zurich, Switzerland"},{"issue":"9","key":"10.1002\/14651858.CD003412.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archderm.138.9.1165","article-title":"Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma","volume":"138","author":"Schumack","year":"2002","journal-title":"Archives of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-0960.2010.00626.x","article-title":"PEP005 (Ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomised phase IIa trial","volume":"51","author":"Siller","year":"2010","journal-title":"Australasian Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archderm.142.2.187","article-title":"Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face","volume":"142","author":"Essers","year":"2006","journal-title":"Archives of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD003412.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(08)70260-2","article-title":"Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up","volume":"9","author":"Mosterd","year":"2008","journal-title":"Lancet Oncology"},{"issue":"9447","key":"10.1002\/14651858.CD003412.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(04)17399-6","article-title":"Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial","volume":"364","author":"Smeets","year":"2004","journal-title":"Lancet"},{"issue":"17","key":"10.1002\/14651858.CD003412.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ejca.2014.08.018","article-title":"Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up","volume":"50","author":"Van Loo","year":"2014","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1562\/0031-8655(2000)071<0724:PTOSBC>2.0.CO;2","article-title":"Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: A comparison of two light sources","volume":"71","author":"Soler","year":"2000","journal-title":"Photochemistry and Photobiology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003412.pub3-BIB0066|cit66","first-page":"50","article-title":"Ingenol mebutate 0.05% gel under occlusion is efficacious in treating superficial basal cell carcinoma","volume":"171","author":"Rosen","year":"2014","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0067|cit67","unstructured":"Sterry W Bichel J Andres K Ginkel AM Imiquimod 5% cream for 6 weeks with occlusion treating superficial BCC 8th World Congress on cancers of the skin, Zurich, Switzerland 2001 61"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0068|cit68","unstructured":"Sterry W Bichel J Ding L Ginkel AM Imiquimod 5% cream for 6 weeks with occlusion treating nodular BCC 8th World Congress on Cancer of the skin, Zurich, Switzerland 2001"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1365-2133.2002.05069.x","article-title":"Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion","volume":"147","author":"Sterry","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"-","key":"10.1002\/14651858.CD003412.pub3-BIB0070|cit70","first-page":"p61","article-title":"Imiquimod 5% cream for 6 weeks with occlusion treating superficial BCC","volume":"-","author":"Sterry","year":"2001","journal-title":"8th World Congress on cancers of the skin, Zurich, Switzerland"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0071|cit71","unstructured":"Sterry W Bichel J Ding L Ginkel AM Imiquimod 5% cream for 6 weeks with occlusion treating nodular BCC 8th World Congress on Cancer of the skin, Zurich, Switzerland 2001"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1365-2133.2002.05069.x","article-title":"Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion","volume":"147","author":"Sterry","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"11","key":"10.1002\/14651858.CD003412.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1468-3083.2008.02803.x","article-title":"A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20mm), with a 12-month follow-up","volume":"22","author":"Szeimies","year":"2008","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/lsm.22032","article-title":"Single treatment of non-melanoma skin cancers using a pulsed-dye laser with stacked pulses","volume":"44","author":"Tran","year":"2012","journal-title":"Lasers in Surgery and Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003412.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2133.2001.04141.x","article-title":"Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial","volume":"144","author":"Wang","year":"2000","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0076|cit76","doi-asserted-by":"crossref","unstructured":"Al-Niaimi F Sheth N Kurwa HA Mallipeddi R Photodynamic therapy followed by Mohs micrographic surgery compared to mohs micrographic surgery alone for the treatment of basal cell carcinoma: results of a pilot single-blinded randomised controlled trial Journal of Cutaneous and Aesthetic Surgery 2015 8 2 88 91","DOI":"10.4103\/0974-2077.158443"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/bjd.13066","article-title":"Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma","volume":"171","author":"Arits","year":"2014","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2133.2007.07996.x","article-title":"A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma","volume":"157","author":"Berroeta","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0079|cit79","first-page":"24","article-title":"Imiquimod 5% cream as adjunctive therapy for primary solitary, nodular basal cell carcinomas before Mohs Micrographic Surgery: a randomized, double blind vehicle-controlled study","volume":"35","author":"Butler","year":"2009","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pdpdt.2016.08.003","article-title":"Single treatment of low-risk basal cell carcinomas with pulsed dye laser-mediated photodynamic therapy (PDL-PDT) compared with photodynamic therapy (PDT): a controlled, investigator-blinded, intra-individual prospective study","volume":"16","author":"\u010carija","year":"2016","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"issue":"9880","key":"10.1002\/14651858.CD003412.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(12)62166-7","article-title":"Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)","volume":"381","author":"Cho","year":"2013","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD003412.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.jid.5700460","article-title":"Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy","volume":"126","author":"Haas","year":"2006","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0083|cit83","doi-asserted-by":"crossref","unstructured":"Dessinioti C Plaka M Stratigos AJ Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial Future Oncology 2014 10 6 927 36","DOI":"10.2217\/fon.14.50"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0084|cit84","unstructured":"Enhanced efficacy of photodynamic therapy in combination with 5% imiquimod -a randomised, prospective, observer-blinded study in patients with non melanoma skin cancer www.clinicaltrialsregister.eu\/ctr-search\/search?query=2013-000092-33"},{"issue":"11","key":"10.1002\/14651858.CD003412.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/jdv.14989","article-title":"Laser-assisted photodynamic therapy for superficial basal cell carcinoma and Bowen's disease: a randomized intrapatient comparison between a continuous and a fractional ablative CO2 laser mode","volume":"32","author":"Genouw","year":"2018","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hed.24991","article-title":"Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results","volume":"40","author":"Groselj","year":"2018","journal-title":"Head & Neck"},{"issue":"4","key":"10.1002\/14651858.CD003412.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaad.2004.04.009","article-title":"Randomised, controlled surgical trial of preoperative tumour curettage of basal cell carcinoma in Mohs micrographic surgery","volume":"51","author":"Huang","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003412.pub3-BIB0088|cit88","first-page":"100","article-title":"A randomized, controlled trial of portable compared with conventional photodynamic therapy for superficial nonmelanoma skin cancer","volume":"179","author":"Ibbotson","year":"2018","journal-title":"British Journal of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD003412.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/dsu.12242","article-title":"Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate","volume":"39","author":"Lippert","year":"2013","journal-title":"Dermatologic Surgery"},{"issue":"14","key":"10.1002\/14651858.CD003412.pub3-BIB0090|cit90","first-page":"6476","article-title":"Study of ALA and small dosage of HPD photodynamic therapy (HPD-PDT) in treatment of skin cancer","volume":"28","author":"Lu","year":"2017","journal-title":"Biomedical Research (India)"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.140.1.26","article-title":"Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes","volume":"140","author":"Lui","year":"2004","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0092|cit92","doi-asserted-by":"crossref","unstructured":"Migden MR Guminski A Gutzmer R Dirix L Lewis KD Combemale P Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial Lancet Oncology 2015 16 6 716 28","DOI":"10.1016\/S1470-2045(15)70100-2"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0093|cit93","unstructured":"To evaluate the safety, local tolerability, PK and PD of LDE225 on sporadic superficial and nodular skin basal cell carcinomas (sBCC) clinicaltrials.gov\/ct2\/show\/NCT01033019"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/09546634.2018.1484558","article-title":"Is a single day patient friendly methyl aminolevulinate photodynamic therapy illumination scheme for superficial basal cell carcinoma feasible? A randomized multicenter pilot trial","volume":"30","author":"Nguyen","year":"2019","journal-title":"Journal of Dermatological Treatment"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0095|cit95","first-page":"318","article-title":"Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study","volume":"85","author":"Quirk","year":"2010","journal-title":"Cutis"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1188\/14.ONF.57-65","article-title":"Nonmelanoma skin cancer: disease-specific quality-of-life concerns and distress","volume":"41","author":"Radiotis","year":"2014","journal-title":"Oncology Nursing Forum"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pdpdt.2007.04.004","article-title":"Comparison of aminolevulinic acid (ALA)-thermogel-PSDT with methyl-ALA-thermogel-PDT in basal cell carcinoma","volume":"4","author":"Schleier","year":"2007","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"issue":"23","key":"10.1002\/14651858.CD003412.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00042728-200601000-00011","article-title":"Pilot study of Imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular and basal cell carcinoma","volume":"32","author":"Spencer","year":"2006","journal-title":"Dermatologic Surgery"},{"issue":"23","key":"10.1002\/14651858.CD003412.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1113538","article-title":"Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome","volume":"366","author":"Tang","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2133.2012.10924.x","article-title":"Imiquimod 5% cream as pre-treatment of Mohs Micrographic Surgery for nodular basal cell carcinoma in the face, a prospective randomized controlled study","volume":"167","author":"Van der Geer","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2340\/00015555-1448","article-title":"Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial","volume":"92","author":"Vijlder","year":"2012","journal-title":"Acta Dermato-Venereologica"},{"issue":"7","key":"10.1002\/14651858.CD003412.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bjps.2013.03.008","article-title":"Treatment of basal cell carcinoma with surgical excision and perilesional interferon-alpha","volume":"66","author":"Wettstein","year":"2013","journal-title":"Journal of Plastic, Reconstructive and Aesthetic Surgery"},{"issue":"7","key":"10.1002\/14651858.CD003412.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/DSS.0000000000001106","article-title":"Pulsed CO2 laser ablation of superficial basal cell of limbs and trunk: a comparative randomized clinical trial with cryotherapy and surgical ablation","volume":"43","author":"Zane","year":"2017","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0105|cit105","unstructured":"Bunker C 5 Fluoracil\/Adrenaline injectable gel in basal cell carcinoma National Research Register"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0106|cit106","unstructured":"A comparison between efficacy and safety of 585-nanometer pulsed dye laser alone and with cryotherapy in treating superficial basal cell carcinoma en.irct.ir\/trial\/25544"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0107|cit107","unstructured":"Effect of penetration enhancers in topical photodynamic therapy doi.org\/10.1186\/ISRCTN92678315"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0108|cit108","first-page":"258","article-title":"The effects of Ella light power combined with imiquimod cream on basal cell carcinoma","volume":"8","author":"Kang","year":"2018","journal-title":"Anti-Tumor Pharmacy"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0109|cit109","first-page":"951","article-title":"Effect of adriamycin combined with cisplatin on basal cell carcinoma and the level of vascular endothelial growth factor in patients","volume":"6","author":"Ma","year":"2018","journal-title":"Anti-tumor Pharmacy"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0110|cit110","unstructured":"Efficacy study, randomized, controlled, with CIGB-128-A injected perilesional in basal cell carcinoma in different treatment schedules (InCarbacel-V study) registroclinico.sld.cu\/en\/trials\/RPCEC00000147-En"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0111|cit111","unstructured":"Electrochemotherapy compared with radiotherapy for the treatment of basal cell carcinoma www.clinicaltrialsregister.eu\/ctr-search\/search?query=2016-002255-25"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0112|cit112","unstructured":"Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma (SCIN) clinicaltrials.gov\/ct2\/show\/NCT02242929"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0113|cit113","unstructured":"A randomized, double blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA (Ameluz\u00ae) and BF-RhodoLED\u00ae in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT) clinicaltrials.gov\/ct2\/show\/NCT03573401"},{"issue":"7","key":"10.1002\/14651858.CD003412.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1524-4725.1991.tb03655.x","article-title":"Prediction of subclinical tumor infiltration in basal cell carcinoma","volume":"17","author":"Breuninger","year":"1991","journal-title":"Journal of Dermatologic Surgery and Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12967-017-1225-5","article-title":"Basal cell carcinoma: 10-year experience with electrochemotherapy","volume":"15","author":"Campana","year":"2017","journal-title":"Journal of Translational Medicine"},{"issue":"11","key":"10.1002\/14651858.CD003412.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/archderm.136.11.1327","article-title":"Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer","volume":"136","author":"Chiller","year":"2000","journal-title":"Archives of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/bjd.16838","article-title":"Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis","volume":"179","author":"Collier","year":"2018","journal-title":"British Journal of Dermatology"},{"issue":"S2","key":"10.1002\/14651858.CD003412.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1038\/modpathol.3800512","article-title":"Basal cell carcinoma: biology, morphology and clinical implications","volume":"19","author":"Crowson","year":"2006","journal-title":"Modern Pathology"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1751-1097.2010.00735.x","article-title":"Basal cell carcinoma: what\u2019s new under the sun","volume":"86","author":"Dessinioti","year":"2010","journal-title":"Photochemistry and Photobiology"},{"issue":"7","key":"10.1002\/14651858.CD003412.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/M18-0678","article-title":"Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis","volume":"169","author":"Drucker","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.0366-077X.2003.05630.x","article-title":"Imiquimod in basal cell carcinoma: how does it work?","volume":"149","author":"Dummer","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"7365","key":"10.1002\/14651858.CD003412.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bmj.325.7365.652","article-title":"Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis","volume":"325","author":"Fergusson","year":"2002","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2133.1982.tb01728.x","article-title":"Episodic progression and regression of basal cell carcinomas","volume":"106","author":"Franchimont","year":"1982","journal-title":"British Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/archderm.134.2.207","article-title":"Photodynamic therapy in dermatology","volume":"134","author":"Fritsch","year":"1998","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0125|cit125","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime, Inc.)"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bjps.2005.02.010","article-title":"Do basal cell carcinomas recur after complete conventional surgical excision?","volume":"58","author":"Griffiths","year":"2005","journal-title":"British Journal of Plastic Surgery"},{"issue":"4","key":"10.1002\/14651858.CD003412.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"528\u201336","DOI":"10.1067\/mjd.2001.114742","article-title":"Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona","volume":"45","author":"Harris","year":"2001","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0128|cit128","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from http:\/\/handbook.cochrane.org"},{"issue":"9","key":"10.1002\/14651858.CD003412.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1524-4725.1994.tb00149.x","article-title":"Mohs micrographic surgery local recurrences","volume":"20","author":"Hruza","year":"1994","journal-title":"Journal of Dermatologic Surgery and Oncology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0130|cit130","volume-title":"Rook's Textbook of Dermatology, Ninth Edition","author":"Ibbotson","year":"2016"},{"issue":"5268","key":"10.1002\/14651858.CD003412.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","article-title":"Human homolog of patched, a candidate gene for the basal cell nevus syndrome","volume":"272","author":"Johnson","year":"1996","journal-title":"Science"},{"issue":"4","key":"10.1002\/14651858.CD003412.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2010.02.040","article-title":"Recurrent basal cell carcinoma following ablative laser procedures","volume":"64","author":"Jung","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003412.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"555\u20139","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R","article-title":"Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA","volume":"81","author":"Karagas","year":"1999","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jid.2016.11.021","article-title":"Treatment of low-risk basal cell carcinoma","volume":"137","author":"Kelleners-Smeets","year":"2017","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jaad.2005.03.038","article-title":"Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas","volume":"53","author":"Kimyai-Asadi","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00247-008-1015-6","article-title":"Radiation-sensitive genetically susceptible pediatric sub-populations","volume":"39","author":"Kleinerman","year":"2009","journal-title":"Pediatric Radiology"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0138|cit138","volume-title":"Rook's Textbook of Dermatology, Ninth Edition","author":"Madan","year":"2016"},{"issue":"10","key":"10.1002\/14651858.CD003412.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1524-4725.1996.tb00588.x","article-title":"Cryosurgery in the treatment of basal cell carcinoma: assessment of one and two freeze-thaw cycle schedules","volume":"22","author":"Mallon","year":"1996","journal-title":"Dermatologic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0190-9622(91)70001-I","article-title":"Biology of basal cell carcinoma (part 1)","volume":"24","author":"Miller","year":"1991","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"7","key":"10.1002\/14651858.CD003412.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0142|cit142","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1468-3083.2011.04347.x","article-title":"Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma","volume":"27","author":"Mosterd","year":"2013","journal-title":"Journal of the European Academy of Dermatology and Venereology : JEADV"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0143|cit143","volume-title":"Greenfield's surgery: Scientific principles & practice","author":"Mulholland","year":"2012"},{"issue":"9","key":"10.1002\/14651858.CD003412.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1524-4725.2009.01240.x","article-title":"Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome","volume":"35","author":"Muller","year":"2009","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0145|cit145","unstructured":"National Cancer Intelligence Network (NCIN) Data Briefing. The importance of skin cancer registration; September 2010 Available at www.ncin.org.uk\/publications\/data_briefings\/skin_cancer_registration"},{"issue":"5","key":"10.1002\/14651858.CD003412.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.bjps.2015.12.023","article-title":"Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites","volume":"69","author":"Nizamoglu","year":"2016","journal-title":"Journal of Plastic, Reconstructive & Aesthetic Surgery"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0147|cit147","doi-asserted-by":"crossref","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch13"},{"issue":"10","key":"10.1002\/14651858.CD003412.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.1365-4362.2002.01573.x","article-title":"Multiple nonmelanoma skin cancer in an exposed Australian population","volume":"41","author":"Raasch","year":"2002","journal-title":"International Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1524-4725.1996.tb00316.x","article-title":"Basal cell carcinoma identification and treatment of the high-risk patient","volume":"22","author":"Randle","year":"1996","journal-title":"Dermatologic Surgery"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0150|cit150","unstructured":"Review Manager (RevMan) [Computer program]. Version 5.4 The Cochrane Collaboration"},{"issue":"s2","key":"10.1002\/14651858.CD003412.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2133.2007.08273.x","article-title":"Epidemiology and aetiology of basal cell carcinoma","volume":"157","author":"Roewert-Huber","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2010.12.038","article-title":"Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response","volume":"66","author":"Rosen","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-4725.1989.tb03166.x","article-title":"Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up","volume":"15","author":"Rowe","year":"1989","journal-title":"Journal of Dermatologic Surgery and Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s13063-017-2244-5","article-title":"Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey","volume":"18","author":"Schlessinger","year":"2017","journal-title":"Trials"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0157|cit157","volume-title":"GRADE handbook","author":"Sch\u00fcnemann","year":"2013"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2133.2002.04804.x","article-title":"Variations of basal cell carcinomas according to gender, age, location and histopathological subtype","volume":"147","author":"Scrivener","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/lsm.20787","article-title":"The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas","volume":"41","author":"Shah","year":"2009","journal-title":"Lasers in Surgery and Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.taap.2013.09.021","article-title":"Green tea polyphenol,(\u2212)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting \u03b2-catenin signaling","volume":"273","author":"Singh","year":"2013","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD003412.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/BF00402629","article-title":"The effect of 5-fluorouracil on inhibition of epidermal DNA synthesis in vivo: a comparison of the effect of formulations and a prodrug of 5-FU","volume":"282","author":"Sloan","year":"1990","journal-title":"Archives of Dermatological Research"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.2008.08666.x","article-title":"Guidelines for the management of basal cell carcinoma","volume":"159","author":"Telfer","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/120347540500900104","article-title":"Metastatic basal cell carcinoma: report of two cases and literature review","volume":"9","author":"Ting","year":"2005","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"issue":"6","key":"10.1002\/14651858.CD003412.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaad.2006.02.035","article-title":"Long-term follow-up of basal cell carcinomas treated with perilesional interferon alfa 2b as monotherapy","volume":"54","author":"Tucker","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD003412.pub3-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jaad.2018.12.028","article-title":"Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study","volume":"80","author":"Nelemans","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.cji.0000187958.38179.a9","article-title":"Antitumor efficacy of the novel chemotherapeutic agent coramsine is potentiated by cotreatment with CpG-containing oligodeoxynucleotides","volume":"29","author":"Most","year":"2006","journal-title":"Journal of Immunotherapy"},{"key":"10.1002\/14651858.CD003412.pub3-BIB0167|cit167","unstructured":"Venables ZC Nijsten TA Wong KF Autier P Broggio J Deas A Epidemiology of basal and cutaneous squamous cell carcinoma in the United Kingdom 2013-2015: a cohort study British Journal of Dermatology 10.1111\/bjd.17873"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"359\u201372","DOI":"10.1111\/bjd.15321","article-title":"Epidemiology of basal cell carcinoma: scholarly review","volume":"177","author":"Verkouteren","year":"2017","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/phpp.12148","article-title":"Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis","volume":"31","author":"Wang","year":"2015","journal-title":"Photodermatology, Photoimmunology & Photomedicine"},{"issue":"3","key":"10.1002\/14651858.CD003412.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archderm.1987.01660270078019","article-title":"Surgical margins for basal cell carcinoma","volume":"123","author":"Wolf","year":"1987","journal-title":"Archives of Dermatology"},{"issue":"7418","key":"10.1002\/14651858.CD003412.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.327.7418.794","article-title":"Basal cell carcinoma","volume":"327","author":"Wong","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003412.pub3-BIB0172|cit172","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003412","article-title":"Interventions for basal cell carcinoma of the skin","author":"Bath-Hextall","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003412.pub3-BIB0173|cit173","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003412.pub2","article-title":"Interventions for basal cell carcinoma of the skin","author":"Bath-Hextall","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:04:50Z","timestamp":1760979890000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003412.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":173,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003412.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]}}}